Old Web
English
Sign In
Acemap
>
authorDetail
>
Garry Schwartz
Garry Schwartz
Pharmacodynamics
Pharmacokinetics
Medicine
Cancer
Capecitabine
2
Papers
37
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Erlotinib 'dosing-to-rash': a phase II intrapatient dose escalation and pharmacologic study of erlotinib in previously treated advanced non-small cell lung cancer
2011
British Journal of Cancer
Alain C. Mita
Kyriakos P. Papadopoulos
M.J.A. de Jonge
Garry Schwartz
Jaap Verweij
Monica M. Mita
A. Ricart
Q S-C Chu
Anthony W. Tolcher
Leslie Wood
S McCarthy
M. Hamilton
Kenneth K. Iwata
Bret Wacker
Karsten Witt
Eric K. Rowinsky
Show All
Source
Cite
Save
Citations (37)
A phase I, pharmacokinetic (PK) and pharmacodynamic (PD) study of the combination of an oral antimicrotubular agent, DJ-927 (D), and capecitabine (C) in patients (Pts) with advanced solid tumors
2005
Journal of Clinical Oncology
Muralidhar Beeram
W. M. Saif
John Sarantopoulos
Garry Schwartz
Amita Patnaik
Anthony W. Tolcher
F Mehdi
Kevie Feit
C. H. Takimoto
Show All
Source
Cite
Save
Citations (0)
1